0

Close
 
Upcoming Allied Market Research
2023
Prenatal Dna Sequencing Market

Prenatal DNA Sequencing Market

by APPLICATION (Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS, Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A00445
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Prenatal Dna Sequencing Market

Request Now !

DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant women’s blood to reveal the full genetic code of a fetus. Prenatal DNA sequencing is used to sequence the whole genome of unborn baby that effectively detects the diseases or disorder such as Down syndrome, cystic fibrosis, thalassemia and cancer. The wide acceptance and adoption of prenatal DNA sequencing technology would have huge impact on  public health care sector . The potential application of sequencing technology is growing immensely.. Based on this sequencing technology, several laboratories and companies have launched diagnostic  test. Wide use and effective application of prenatal DNA sequencing increased the demand for sequencing instruments and reagents market. However, it requires huge amount for repetitive sequencing that makes it too expensive for routine use. Companies such as Illumina charge $9,500 to sequence the genome of an adult and fetal DNA sequencing, on the other hand costs much higher. 

The prenatal DNA sequencing market is segmented based on the application and geography. Prenatal DNA sequencing techniques are used to detect the diseases such as Hemophilia Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS and Cancer. Geographically, the prenatal DNA sequencing market is segmented into North America, Asia Pacific, Europe, and LAMEA .

KEY BENEFITS 

  • In-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
  • Comprehensive analysis of the factors that drive and restrict the growth of the prenatal DNA sequencing market is provided
  • Key regulatory guidelines in various regions, which impact the prenatal DNA sequencing market are critically examined 
  • Quantitative analysis of the current market and estimations are provided to showcase the financial calibre of the prenatal DNA sequencing market
  • Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
  • Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the prenatal DNA sequencing market

 Prenatal DNA Sequencing Market Report Highlights

Aspects Details
By APPLICATION
  • Hemophilia
  • Down Syndrome
  • Cystic Fibrosis
  • Autism
  • DiGeorge Syndrome
  • AIDS
  • Cancer
  • Others
By GEOGRAPHY
  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PRENATAL DNA SEQUENCING MARKET, BY APPLICATION

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Application

    • 4.2. Hemophilia

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Down Syndrome

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Cystic Fibrosis

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Autism

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. DiGeorge Syndrome

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. AIDS

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Cancer

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. Others

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

  • CHAPTER 5: PRENATAL DNA SEQUENCING MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Application

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Prenatal Dna Sequencing Market

        • 5.2.4.1. Market Size and Forecast, By Application

      • 5.2.5. Canada Prenatal Dna Sequencing Market

        • 5.2.5.1. Market Size and Forecast, By Application

      • 5.2.6. Mexico Prenatal Dna Sequencing Market

        • 5.2.6.1. Market Size and Forecast, By Application

    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Application

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Prenatal Dna Sequencing Market

        • 5.3.4.1. Market Size and Forecast, By Application

      • 5.3.5. Germany Prenatal Dna Sequencing Market

        • 5.3.5.1. Market Size and Forecast, By Application

      • 5.3.6. Italy Prenatal Dna Sequencing Market

        • 5.3.6.1. Market Size and Forecast, By Application

      • 5.3.7. Spain Prenatal Dna Sequencing Market

        • 5.3.7.1. Market Size and Forecast, By Application

      • 5.3.8. UK Prenatal Dna Sequencing Market

        • 5.3.8.1. Market Size and Forecast, By Application

      • 5.3.9. Russia Prenatal Dna Sequencing Market

        • 5.3.9.1. Market Size and Forecast, By Application

      • 5.3.10. Rest Of Europe Prenatal Dna Sequencing Market

        • 5.3.10.1. Market Size and Forecast, By Application

    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Application

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Prenatal Dna Sequencing Market

        • 5.4.4.1. Market Size and Forecast, By Application

      • 5.4.5. Japan Prenatal Dna Sequencing Market

        • 5.4.5.1. Market Size and Forecast, By Application

      • 5.4.6. India Prenatal Dna Sequencing Market

        • 5.4.6.1. Market Size and Forecast, By Application

      • 5.4.7. South Korea Prenatal Dna Sequencing Market

        • 5.4.7.1. Market Size and Forecast, By Application

      • 5.4.8. Australia Prenatal Dna Sequencing Market

        • 5.4.8.1. Market Size and Forecast, By Application

      • 5.4.9. Thailand Prenatal Dna Sequencing Market

        • 5.4.9.1. Market Size and Forecast, By Application

      • 5.4.10. Malaysia Prenatal Dna Sequencing Market

        • 5.4.10.1. Market Size and Forecast, By Application

      • 5.4.11. Indonesia Prenatal Dna Sequencing Market

        • 5.4.11.1. Market Size and Forecast, By Application

      • 5.4.12. Rest of Asia Pacific Prenatal Dna Sequencing Market

        • 5.4.12.1. Market Size and Forecast, By Application

    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Application

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Prenatal Dna Sequencing Market

        • 5.5.4.1. Market Size and Forecast, By Application

      • 5.5.5. South Africa Prenatal Dna Sequencing Market

        • 5.5.5.1. Market Size and Forecast, By Application

      • 5.5.6. Saudi Arabia Prenatal Dna Sequencing Market

        • 5.5.6.1. Market Size and Forecast, By Application

      • 5.5.7. UAE Prenatal Dna Sequencing Market

        • 5.5.7.1. Market Size and Forecast, By Application

      • 5.5.8. Argentina Prenatal Dna Sequencing Market

        • 5.5.8.1. Market Size and Forecast, By Application

      • 5.5.9. Rest of LAMEA Prenatal Dna Sequencing Market

        • 5.5.9.1. Market Size and Forecast, By Application

  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning,2022

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. Company 1

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Company 2

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Company 3

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Company 4

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Company 5

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Company 6

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Company 7

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Company 8

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. Company 9

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Company 10

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PRENATAL DNA SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR HEMOPHILIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR DOWN SYNDROME, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR CYSTIC FIBROSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR AUTISM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR DIGEORGE SYNDROME, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR AIDS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PRENATAL DNA SEQUENCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PRENATAL DNA SEQUENCING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA PRENATAL DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. U.S. PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. CANADA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. MEXICO PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. EUROPE PRENATAL DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. EUROPE PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. FRANCE PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. GERMANY PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. ITALY PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. SPAIN PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. UK PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. RUSSIA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. REST OF EUROPE PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. ASIA-PACIFIC PRENATAL DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 26. ASIA-PACIFIC PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. CHINA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. JAPAN PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. INDIA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. SOUTH KOREA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. AUSTRALIA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. THAILAND PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. MALAYSIA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. INDONESIA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. REST OF ASIA PACIFIC PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. LAMEA PRENATAL DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. LAMEA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. BRAZIL PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. SOUTH AFRICA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. SAUDI ARABIA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. UAE PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. ARGENTINA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. REST OF LAMEA PRENATAL DNA SEQUENCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. COMPANY 1: KEY EXECUTIVES
  • TABLE 45. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 46. COMPANY 1: OPERATING SEGMENTS
  • TABLE 47. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 48. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 49. COMPANY 2: KEY EXECUTIVES
  • TABLE 50. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 51. COMPANY 2: OPERATING SEGMENTS
  • TABLE 52. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 53. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 54. COMPANY 3: KEY EXECUTIVES
  • TABLE 55. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 56. COMPANY 3: OPERATING SEGMENTS
  • TABLE 57. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 58. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 59. COMPANY 4: KEY EXECUTIVES
  • TABLE 60. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 61. COMPANY 4: OPERATING SEGMENTS
  • TABLE 62. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 63. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 64. COMPANY 5: KEY EXECUTIVES
  • TABLE 65. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 66. COMPANY 5: OPERATING SEGMENTS
  • TABLE 67. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 68. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 69. COMPANY 6: KEY EXECUTIVES
  • TABLE 70. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 71. COMPANY 6: OPERATING SEGMENTS
  • TABLE 72. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 73. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 74. COMPANY 7: KEY EXECUTIVES
  • TABLE 75. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 76. COMPANY 7: OPERATING SEGMENTS
  • TABLE 77. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 78. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. COMPANY 8: KEY EXECUTIVES
  • TABLE 80. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 81. COMPANY 8: OPERATING SEGMENTS
  • TABLE 82. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 83. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. COMPANY 9: KEY EXECUTIVES
  • TABLE 85. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 86. COMPANY 9: OPERATING SEGMENTS
  • TABLE 87. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 88. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. COMPANY 10: KEY EXECUTIVES
  • TABLE 90. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 91. COMPANY 10: OPERATING SEGMENTS
  • TABLE 92. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 93. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PRENATAL DNA SEQUENCING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PRENATAL DNA SEQUENCING MARKET
  • FIGURE 3. SEGMENTATION PRENATAL DNA SEQUENCING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PRENATAL DNA SEQUENCING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPRENATAL DNA SEQUENCING MARKET
  • FIGURE 11. PRENATAL DNA SEQUENCING MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 12. PRENATAL DNA SEQUENCING MARKET FOR HEMOPHILIA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PRENATAL DNA SEQUENCING MARKET FOR DOWN SYNDROME, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PRENATAL DNA SEQUENCING MARKET FOR CYSTIC FIBROSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PRENATAL DNA SEQUENCING MARKET FOR AUTISM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. PRENATAL DNA SEQUENCING MARKET FOR DIGEORGE SYNDROME, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. PRENATAL DNA SEQUENCING MARKET FOR AIDS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. PRENATAL DNA SEQUENCING MARKET FOR CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. PRENATAL DNA SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: PRENATAL DNA SEQUENCING MARKET
  • FIGURE 26. Top player positioning, 2022
  • FIGURE 27. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Prenatal Dna Sequencing Market

Start reading.
This Report and over 67,566+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers